News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Study Identifies Protein Signature That Could Help Detect Advanced Fibrosis in Liver Disease
October 9, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Could Quitting Ultra-Processed Food Boost Your Mental Health?
October 1, 2026 - Media Coverage
- Clinical and Translational Science Awards (CTSA) Program
NIH-Funded Study Shows Sound Sleep Supports Immune Function
September 21, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Adults who cut back on sleep for six weeks had increased markers of inflammation.
Nationwide IRB Reliance Agreement Aimed at Speeding Research Reaches 1,000 Signatories
August 3, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Our Impact on Research Operations
The Streamlined, Multisite, Accelerated Resources for Trials (SMART) Institutional Review Board (IRB) agreement has reached 1,000 participating sites, making it one of the largest medical research study reliance agreements in the United States.
COVID-19 Hospitalization May Increase Heart Failure Risk
July 15, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- National Clinical Cohort Collaborative (N3C)
- Our Impact on Big Data
A large, retrospective study using National COVID Cohort Collaborative (N3C) data revealed that people who had been hospitalized with COVID-19 were more likely to develop heart failure during their recovery than people who had been hospitalized without COVID-19.
Study Finds Immune Dysfunction Is a Significant Risk Factor for COVID-19 Breakthrough Infection
June 3, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
The National COVID Cohort Collaborative Data Enclave helps researchers identify a link between COVID-19 breakthrough infections and people with abnormal or impaired immune systems.
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
June 2, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
A large NCATS-coordinated, randomized, placebo-controlled clinical trial showed that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — substantially improved clinical status and reduced deaths but did not significantly shorten time to recovery.
Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
March 23, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research supported in part by NCATS. The study of a potential treatment for the condition, known as bronchopulmonary dysplasia, appears in The New England Journal of Medicine.